Missouri University of Science and Technology

Scholars' Mine
Engineering Management and Systems
Engineering Faculty Research & Creative Works

Engineering Management and Systems
Engineering

03 Nov 2020

A Markov Chain Approach for Forecasting Progression of Opioid
Addiction
Abhijit Gosavi
Missouri University of Science and Technology, gosavia@mst.edu

Susan L. Murray
Missouri University of Science and Technology, murray@mst.edu

N. Karagiannis

Follow this and additional works at: https://scholarsmine.mst.edu/engman_syseng_facwork
Part of the Operations Research, Systems Engineering and Industrial Engineering Commons,
Psychology Commons, and the Substance Abuse and Addiction Commons

Recommended Citation
A. Gosavi et al., "A Markov Chain Approach for Forecasting Progression of Opioid Addiction," Proceedings
of the 2020 IISE Annual Conference (2020, Virtual), pp. 399-404, Institute of Industrial and Systems
Engineers (IISE), Nov 2020.

This Article - Conference proceedings is brought to you for free and open access by Scholars' Mine. It has been
accepted for inclusion in Engineering Management and Systems Engineering Faculty Research & Creative Works by
an authorized administrator of Scholars' Mine. This work is protected by U. S. Copyright Law. Unauthorized use
including reproduction for redistribution requires the permission of the copyright holder. For more information,
please contact scholarsmine@mst.edu.

Proceedings of the 2020 IISE Annual Conference
L. Cromarty, R. Shirwaiker, P. Wang, eds.

A Markov Chain Approach for Forecasting Progression of Opioid
Addiction
Abstract ID: 788550
A. Gosavi and S.L. Murray
Missouri University of Science and Technology
Rolla, MO 65409
N. Karagiannis
Winston-Salem State University
Winston Salem, NC 27110
Abstract
The U.S. is currently facing an opioid crisis. Naltrexone is a common treatment for drug addiction; it reduces the
desire to take opiates. However, addicts often stop treatment or continue to use opioids while in treatment. This results
in increased fatalities and associated costs. A Markov-chain model is presented to analyze the progression of opioid
addiction to assist the medical community in developing appropriate treatments. The model includes patients who
continue opiate use while on naltrexone (blocked patients) and those who use opiates after missing naltrexone doses
(unblocked patients). The other types of patients are abstinent (the best-case scenario) and dropout (the worst-case
scenario). The Markov-chain model is built on probability estimates of transitions from one stage to another; the model
predicts the proportion of patients in the different stages for a given rate of intervention on dropouts. Many factors,
including psychological, environmental, sociodemographic, and access-to-healthcare, impact transition probabilities
and thereby the observational data used for constructing the Markov-chain model. Markov chains have been used
successfully in predicting the progression of HIV (Human Immunodeficiency Virus) and other diseases. Modeling
statistically provides an offline method, based on existing data, to develop successful strategies for addressing this
public-health crisis.
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1. Introduction
The U.S. is currently facing an opioid crisis in which significant sections of society are getting addicted to chemicals
that affect the brain, making opioid abuse a growing public health problem [1]. More than 702,000 persons have died
from drug overdoses in the last 18 years since 2017 for which data are available with the Centers for Disease Control
and Prevention. This number appears to be increasing every year. In 2017 alone, the number of casualties has exceeded
70,000; this makes opioid abuse one of the leading causes of injury-related casualties in the country [2]. There are two
types of addictions that come under the purview of opioid abuse: (a) abuse of prescription medications,
methamphetamine, (meth for short), tranquilizers, and stimulants (collectively called opioids) and (b) substance
(opiate) abuse. Two widely used prescription medications that often get abused are hydrocodone and oxycodone [1].
Typically, by substance abuse, one means addiction and overdose of alcohol or drugs such as heroin, cocaine, and/or
marijuana. These three drugs (heroin, cocaine, and marijuana) are natural products and are technically called opiates,
while opioids are essentially synthetic products that behave like opiates but are not fully natural and contain one or
more synthetically produced ingredients. Collectively, addiction to opiates and opioids is generally called opioid
abuse, and in this paper, the term “opioid” will mean opiates and/or opioids. Opioid abuse is quite prevalent in the
young adult age group [3]. This work seeks to build upon the research based on sociodemographic risk factors that
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increase susceptibility to such addictions and further use a statistical model rooted in Markov chains for (a) better
understanding the different stages of opioid addiction and (b) potentially determining the rates of intervention needed
to reduce the severity of this disease. In general, addiction arises from psychological factors, demographic factors,
environmental factors, income levels, and lack of access to healthcare and treatments. In particular, a large number of
risk factors have been studied in the young adult population [4], which will be elaborated upon later. Many patients
remain under the radar because of poverty, homelessness, and unwillingness to disclose drug abuse and/or sexuality
due to the unfortunate social stigma attached to such disclosures.
Statistical models such as Markov chains have been widely used successfully in predicting the progression of different
stages of HIV (Human Immunodeficiency Virus) [5] and other diseases and to analyze the different treatment
procedures available. The goal with such models is to reduce the spread of the disease. This is crucial in diseases for
which a cure has not been discovered or if the patient can quickly worsen and progress to a stage where interventions
are not possible. A major merit to developing such statistical models that capture the behavior of patients within a
mathematical (and typically computerized) model is that one can study the effects of clinical intervention strategies
offline. Randomized controlled trials (RCTs) that have a long history in the medical community [6] can often provide
the initial data for statistical models. An advantage of statistical models, such as Markov-chain and discrete-event
simulation, is that they provide a high-fidelity mechanism to test different intervention strategies – after a short RCT
is conducted. A short RCT, for instance, would be 4-6 months long, while a prolonged RCT would have a duration of
4-6 years. The results of prolonged RCTs can be quite negative for some of the patients involved, especially for those
who did not receive the appropriate treatment, but which treatment was inappropriate became clear much later after
all the results came in. Further, prolonged RCTs of this nature can take a long time-period (several months) and are
usually expensive. In the case of opioid abuse and HIV, time is of essence, as the patient may get worse quickly
beyond cure, or in the worst case, actually lose his/her life.
The progression of opioid addiction has been studied via Markov chains in [7], where a short RCT that was 26 weeks
(approximately 6 months) long was conducted. Patients who have dropped out, called dropouts, typically remain in
that stage, as it is naturally difficult to track such patients. Dropping out of treatments for opioid addiction is clearly
the least desirable outcome, as it leads to fatalities in a high proportion of cases. The overarching goal of social
programs is to minimize the probability of this outcome and maximize that of abstinence, i.e., the stage in which the
patient has stopped abusing opioids. The dataset in [7] provides a window to the world of opioid abuse. Very
importantly, this dataset can be analyzed further, via the model presented here, to study and determine the appropriate
rate of intervention on the dropouts (RID) in order to obtain a desired social outcome. RID will be defined herein as
the proportion of the dropped-out patients who are brought back, via active interventions, to the blocked stage, where
the patient returns to taking medications consistently but is still abusing opioids occasionally. Such interventions
include active social interaction with the vulnerable population, as well as hard-copy advertisements (e.g., flyers) for
getting tested and free counselling in locations frequented by vulnerable populations, along with follow-up of patients
through other mechanisms, such as searches in existing databases. For instance, if the patient is homeless, it is likely
that he/she has a history of different shelters visited in the past. In case the patient is a student still enrolled in college,
there are numerous ways to try and reach out to the individual. Clearly, this kind of an intervention requires time,
effort, and money. However, the model presented here shows how critically important interventions of this nature are
if one desires to bring this problem under control in the long run. HIV treatments that have sought to reduce the spread
of the virus have made active efforts to track vulnerable populations, and those efforts have produced a significant
impact on reducing the spread of the virus [8, 9]. Similarly, RID is clearly an important strategy that can help produce
a similar impact on reducing fatalities. In this paper, the goal is to predict the long-term outcomes, i.e., what proportion
of patients will eventually become abstinent and what proportion will drop out, for a given rate of intervention on the
dropout. In other words, the goal is thus to forecast the proportion of patients who will drop out of treatments and how
many will cease using opiates for a given value of RID.

2. Background and Literature Review
A large number of factors, including sociodemographic status, homelessness, parental abuse of drugs, parental mental
health (anxiety, depression, and anger), and prescription history, have been cited as major indicators of increased risk
for opioid abuse within vulnerable populations [4, 10]. Young adults, it has been observed in [11]-[13], are a
particularly vulnerable group for opioid abuse, and some of the factors named below apply specifically to them. The
main sociodemographic and environmental factors considered in the literature are enumerated below via a numbered
list, where the name of the factor is provided in each numbered item and the different categories for the factor
concerned are provided within brackets:
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(i)
(ii)
(iii)
(iv)
(v)
(vi)
(vii)

gender (male, female, gender-variant)
race (White, Hispanic/Latino, African-American, Multi-Racial, Asian/Pacific Islander, Native
American, and Other)
sexual identity (heterosexual, homosexual, bisexual, questioning)
housing status (homeless in the last year, never homeless, ever in foster care)
income level of parents when growing up (middle/high, low)
prescription history of patient and parents (patient prescribed, patient never prescribed, parents
prescribed, parents never prescribed, parents abused drugs)
student status (attending college, completed college, college dropout, never attended college)

A so-called risk profile can be constructed for any individual (typically a young adult) based on the information
gathered via the above list. The risk profile can be used to gauge the probability of getting addicted. The risk profile
is directly related to how vulnerable an individual is to addiction and hence can become very useful in (a) demarcating
patients into different risk groups that share similar characteristics and (b) in developing treatment options
(procedures) for the different groups in the vulnerable population when diagnosed.
Naltrexone is commonly used to reduce addiction to opiates. It diminishes the desire to take opiates and is also used
to treat alcohol addiction, which is often of a less severe magnitude than addiction to the other drugs mentioned above
(marijuana, cocaine, and heroin), and addiction to prescription medications (opioids). Prescription medications that
can become addictive are loosely called opioids and include painkillers and central nervous system depressants, such
as benzodiazepines (Xanax, Valium, and Ativan) used to treat anxiety and sleep disorders. The focus in this study is
on the drugs and opioids, rather than alcohol. Patients who continue to use opiates while on naltrexone treatment
therapy are referred to as blocked patients in the literature, while those who use opiates after having missed numerous
naltrexone doses are called unblocked patients. There are thus two classes of patients using opioids, although they are
under treatment. The best-case scenario is that of patients who are abstinent, while the worst-case scenario is that of
dropout, i.e., dropping out of treatments. The patients who have dropped out are those who were formerly undergoing
treatment but are no longer with the medical care providers. The abstinent patients are those who are responding to
the treatment and have stopped using opiates. Overall, thus, there are four major stages in the process of treatment:
(1) abstinent, (2) blocked, (3) unblocked, and (4) dropout. A clear demarcation of this nature helps the medical
community understand the disease better, as well as diagnose the current state of the patient and determine which steps
can potentially be undertaken to help the patient eventually become abstinent.

3. A Markov-Chain Model
Key numerical outcomes from developing a Markov chain model are: the likelihood of a patient staying in a given
state and the frequency with which the patient can transition to a different state. Markov-chain models can capture the
behavior of a large number of biological systems, and, as stated above, have been utilized in studying the progression
of diseases. A finite discrete-time Markov chain, which will be used in this study, is defined by a finite number of
distinct states of the system, where the state of the system is typically the condition of the system. In this case, the
stage of treatment (abstinent, blocked, unblocked, or dropout) will be equivalent to the state. Thus, there will be four
distinct states in the system under consideration.
3.1. Transition Probabilities
The key to using a Markov chain model is developing estimates of probabilities of transition from one state to another.
In a Markov chain, the underlying assumption in a transition from one state (𝑖) to another (𝑗) is that regardless of
where the system has been in the past before coming to 𝑖, its probability of transition to 𝑗 is a constant that depends
on i and not on where the system has been before coming to i [14]. Thus, if 𝑃(𝑖, 𝑗) denotes the probability of transition
from 𝑖 to 𝑗, then the value of 𝑃(𝑖, 𝑗) depends only on 𝑖 and 𝑗. Since these transition probabilities depend on two discrete
variables (i and j), they can be written in the form of a matrix, P, whose element in the ith row and jth column will
equal 𝑃(𝑖, 𝑗).
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3.2 Steady-State Probabilities
An advantage of setting up the transition probabilities is that one can then compute the long-run or steady-state
behavior of the underlying system. Then, steady-state analysis can estimate what proportion of the affected population
can be found in each of these four states in the long run, i.e., if the system is observed for a long time. The well-known
steady-state equations for computing these proportions, also called steady-state probabilities, are given by (see e.g.,
[14]):
𝛱𝑷 = 𝛱

(1)

∑𝑛𝑖=1 𝛱(𝑖) = 1

(2)

where 𝜫(𝒊) denotes the ith element of the row vector 𝜫, 𝒏 denotes the number of states in the system, and P denotes
the transition probability matrix. In the above, 𝜫(𝒊) will denote the steady-state probability of state i, i.e., the
proportion of time the system can be found in state i in the long run. The equations defined by (1) and (2) can be
solved easily as they form a linear system of equations, allowing for the computation of the values of the steady-state
probabilities after all the elements of the matrix P are estimated.

4. Numerical Results
The numerical results in this work are based on the data drawn from the short RCT conducted in [7]. It is to be noted
that typically in an RCT, there is a main trial in which a medicinal drug is used for treatment and another trial on
different patients in which either a placebo is used or a milder form of the treatment (or the medicinal drug) is used.
Since naltrexone is known to be very effective, the two different types of treatment in [7] differed in the nature of the
social interactions performed to help the patient rather than on the medicinal drug. The stronger (main) trial resulted
in statistically better outcomes, and hence results from that trial are used here. As discussed above, the RID is not
studied in [7], and the novelty of this work is to determine the intensity of RID needed for desirable outcomes. The
data for the Markov chain used in the analysis here are shown via Figure 1, where each transition takes approximately
22 weeks. Note, however, that the transitions from the dropout stage (i.e., RID-related transitions) are not considered
in [7], and this is where this model deviates from the literature. The RID (rate of intervention of dropouts) is the
probability of returning a patient who has dropped out to the blocked state. This probability is denoted by 𝑥 in the
model, as shown in Figure 1. Consequently, the probability of a patient remaining in the dropout state is clearly (1 −
𝑥). Death has not been accounted for separately in this model or in [7], as it is typically associated to the dropout state
discussed above; those in the dropout state will essentially lose their life from the effects of this disease with a high
likelihood. Also, death is an absorbing state that poses a modeling challenge in this setting.
The steady-state probabilities are computed using the matrix equations (1)—(2). A computer program was written in
MATLAB and implemented on a computer using 2.60 GHz Intel Core i7-6700HQ processor and a 64-bit Windows
operating system. The run time of the computer program is very short (a few microseconds), which indicates that this
model can be used easily in practice. Table 1 shows the results of two different RID strategies (named A and B for
convenience) for illustration. In Strategy A, the RID probability (𝑥) is 0.01, i.e., 1 out of 100 dropouts are effectively
transferred to the blocked stage. In Strategy B, the RID probability (𝑥) is 0.5, i.e., half of those who have dropped out
return to the blocked stage. Clearly, Strategy B would require a significantly higher amount of money and effort, as
discussed above in Section 1.
Table 1 shows the dramatically different results from Strategies A and B. Strategy A is reflective of a situation in
which very little effort is made to track the patients who have dropped out, while Strategy B is reflective of that in
which a significant amount of effort is made in this direction. The steady-state percentage for each stage is shown in
Table 1, which essentially equals the steady-state probability, obtained from solving Equations (1)—(2), multiplied
by 100. It is clear from the results in Table 1 that it is imperative to make strong efforts to track the dropouts if one
wishes to reduce the fatalities. With a low effort (Strategy A), a very high percentage of patients (82.27%) will
eventually die, while this percentage is significantly reduced with high effort (Strategy B) to a lower percentage
(8.49%); of course, additional efforts can bring this rate of fatalities even lower. At the same time, the results show
that with a low effort (Strategy A), a very low percentage of patients (13.23%) will eventually become abstinent, while
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this percentage is significantly increased with high effort (Strategy B) to a higher percentage (68.28%). Figure 2 shows
how the steady-state percentages of patients being in the abstinent state and in the dropout state change as the RID
value (𝑥) is varied on a continuous spectrum. The resulting data from Figure 2 can help determine the RID needed to
achieve a desired level of abstinence. It can also be potentially used in public-policy analysis to motivate the need for
additional funds for social programs that can help reduce the intensity of this problem in the long run without waiting
to see the impact of a prolonged RCT.
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Figure 1: A schematic for the Markov chain in which the four states (abstinent, blocked, unblocked, and dropout) are
denoted by four different circles and the number on the connecting arc represent the probability of the associated
transition.
Table 1: Results of the numerical results with the two strategies are shown here.
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Figure 2: The figure shows how the percentages of abstinent and dropout change as RID is varied.
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5. Conclusions
The opioid crisis is a significant public health issue facing the nation. A significant proportion of patients suffering
from opioid abuse remain under the radar because of social stigma and other factors such as homelessness. The opioid
crisis has been getting increasing media attention and needs public health and strategic initiatives for resolution.
However, the existing work does not study the rates of intervention on the dropouts, which can lead to a systemic
understanding of the effort needed to bring about a desired long-run goal of abstinence. This work sought to provide
numerical insights on the rates of intervention on the dropouts in order to reduce the probability of deaths. Industrial
and systems engineers have been studying stochastic processes for many years and have a unique opportunity to team
up with psychologists and the medical community and economists to help develop solution strategies.

References
[1] Substance Abuse and Mental Health Services Administration (SAMHSA), “Results from the 2012 National
Survey on Drug Use and Health: Volume I. Summary of National Findings,” Office of Applied Studies,
Rockville, MD, USA, 2013.
[2] CDC Website, Retrieved on 1/18/2020: https://www.cdc.gov/drugoverdose/index.html
[3] S. E. McCabe, C. J. Boyd, and C. J. Teter, “Subtypes of Nonmedical Prescription Drug Misuse,” Drug and
Alcohol Dependence, vol. 102, no. 1–3, pp. 63–70, 2009.
[4] S.M. Schrager, A. Kecojevic, K. Silva, J. Jackson Bloom, E. Iverson, S.F. Lankenau, “Correlates and
consequences of opioid misuse among high-risk young adults,” Journal of Addiction, 2014.
[5] A. T. Goshu, Z. G. Dessie, Modelling Progression of HIV/AIDS Disease Stages Using Semi-Markov
Processes,” Journal of Data Science, 11(2), 269-280, 2013.
[6] J.A. Schoenberger, “A Randomized, controlled trial of aspirin in persons recovered from myocardial
infarction,” The Journal of the American Medical Association (JAMA), vol. 243, pp. 661-669, 1980.
[7] K. M. Carpenter, H. Jiang, H., M.A. Sullivan, A. Bisaga, S.D. Comer, W. N. Raby, A. Brooks, E.V. Nunes,
“Betting on change: Modeling transitional probabilities to guide therapy development for opioid
dependence,” Psychology of Addictive Behaviors, 23(1), 47, 2009.
[8] H.L. Surratt, C. O’Grady, S.P. Kurtz, M.E. Buttram, M.A. Levi-Minzi, “HIV Testing and Engagement in
Care Among Highly Vulnerable Female Sex Workers: Implications for Treatment As Prevention Models,”
Journal of Health Care for the Poor and Underserved, 25(3), pp. 1360, 2014.
[9] W.A. Haseltine, “Using HIV Self-Tests to Reach Vulnerable Populations,” Forbes, Dec 1,
https://www.forbes.com/sites/williamhaseltine/2019/12/01/using-hiv-self-tests-to-reach-vulnerablepopulations/#1c9aa209549c, 2019.
[10] M.E. Wadsworth, C.D. Santiago, E. Einhorn, E.M. Etter, S. Rienks, H. Markman, “Preliminary Efficacy of
An Intervention to Reduce Psychosocial Stress and Improve Coping in Low-Income Families,” American
Journal of Community Psychology, vol. 48, pp. 257-271, 2010.
[11] S. E. Lankenau, M. Teti, K. Silva, J. J. Bloom, A. Harocopos, M. Treese, “Initiation Into Prescription Opioid
Misuse Amongst Young Injection Drug Users,” International Journal of Drug Policy, vol. 23, no. 1, pp. 37–
44, 2012.
[12] R. Daniulaityte, R.Falck, R. G. Carlson, “Illicit Use of Buprenorphine in a Community Sample of Young
Adult Non-Medical Users of Pharmaceutical Opioids,” Drug and Alcohol Dependence, vol. 122, no. 3, pp.
201–207, 2012.
[13] S. E. Lankenau, S. M. Schrager, K. Silva, A. Kecojevic, J.J. Bloom, C. Wong, E. Iverson, “Misuse of
Prescription and Illicit Drugs Among High-Risk Young Adults in Los Angeles and New York,” Journal of
Public Health Research, vol. 1, no. 1, pp. 22–30, 2012.
[14] S. M. Ross, Introduction to Probability Models (10th ed.), Cambridge, MA:,Academic Press, 2014.

View publication stats

